The Malmberg lab partner in major cancer immunotherapy project
The Malmberg Lab is one of four partners in project that recently was awarded 31 MSEK to study and develop new technologies for cancer immunotherapy. The constellation is led by Professor Bjorn Onfelt at the Royal Institute of Technology in Sweden.
The team focus on T and NK cells and their interactions with tumor cells in both 2D and 3D models.
“One of the most exciting things with this collaboration is the interdisciplinary collaboration between biologists, clinical scientists and phycisists”, says Kalle Mamberg, who holds a Visiting Professor position at the Karolinska Institute.
The key challenge is to identify the right cells for the job of eliminating tumor cells. Onfelt Lab has developed a microchip screening platform with 30.000 wells measuring 22x22micrometer. The confined area and multiple wells allows visualization and quantification of multiple, serial interactions using advanced confocal microscopy. It holds potential to identify subpopulations of cells with increased killing capacity.
Published in major journals, first or last author from Oslo University Hospital.
Edvardsen T(2019) Focused cardiac ultrasound examination is ready for use as a diagnostic tool of acute aortic syndromes in the emergency room Eur Heart J(in press) DOI 10.1093/eurheartj/ehz356, PubMed 31162537
Bretthauer M, Kalager M, Weinberg DS(2019) From Colorectal Cancer Screening Guidelines to Headlines: Beware! Ann Intern Med, 170(10), 734 DOI 10.7326/L19-0086, PubMed 31108525
Ali M, Foldvari Z, Giannakopoulou E, Böschen ML, Strønen E, Yang W, Toebes M, Schubert B, Kohlbacher O, Schumacher TN, Olweus J(2019) Induction of neoantigen-reactive T cells from healthy donors Nat Protoc, 14(6), 1926-1943 DOI 10.1038/s41596-019-0170-6, PubMed 31101906